SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma
Clinical trial NCT00293488 · COMPLETED
Trial details
- NCT number
- NCT00293488
- Sponsor
- Progen Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2008-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.